A carregar...

Monoclonal Antibodies: Leading Actors in the Relapsed/Refractory Multiple Myeloma Treatment

Multiple myeloma is a complex hematologic malignancy, and despite a survival improvement related to the growing number of available therapeutic options since 2000s, it remains an incurable disease with most patients experiencing relapse. However, therapeutic options for this disease are constantly e...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharmaceuticals (Basel)
Main Authors: Morè, Sonia, Petrucci, Maria Teresa, Corvatta, Laura, Fazio, Francesca, Offidani, Massimo, Olivieri, Attilio
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7760536/
https://ncbi.nlm.nih.gov/pubmed/33260960
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph13120426
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!